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Abstract Intestinal malrotation (IM) and cardiovascular
defects (CCVD) are both common congenital defects. We
investigated the prevalence and types of CCVD in a 25-
year IM population, and its association with post-IM-
operative morbidity and mortality. Data on the type of
CCVD, other congenital defects, syndromes, associations,
post-IM-operative morbidity and mortality were retro-
spectively reviewed from the records of IM patients born
between 1980 and 2005. Data were analyzed on (signiﬁ-
cant) differences between CCVD subgroups, and risk
factors for both morbidity and mortality were calculated.
Seventy-seven of 284 IM patients (27.1%) were diagnosed
with a major or minor CCVD (37 and 40 patients,
respectively). Syndromes and associations were more fre-
quently diagnosed in patients with major than with a minor
CCVD (67.6 vs. 40%, respectively). Post-IM-operative
complications, although frequently observed (61%), did not
differ between patients with major and minor CCVD.
Physical CCVD signs before IM surgery increased post-
IM-operative morbidity signiﬁcantly (OR 4.0, 95% CI 1.4–
11.0). Fifteen patients died (19.5%), seven due to
cardiovascular cause. Mortality risk was increased by
intestinal ischemia and post-IM-operative complications
and by major CCVD after correction for age at weight at the
time of IM operation. Congenital cardiovascular defects in
children with intestinal malrotation are common, with high
morbidity and mortality rates after IM operation. Elective
IM surgery in young patients with CCVD should be per-
formed in a centre with adequate paediatric cardiac care.
Beneﬁts of laparoscopic intervention need further study.
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Introduction
Intestinal malrotation (IM) is refers to all abnormalities of
intestinal position and attachment and includes the concept
of atypical malrotation or malrotation variant [1]. It is often
accompanied by a narrow base of the small bowel mesen-
tery. The incidence of IM is 1:500–1:3,500 living births [2,
3]. Volvulus, a rotation of the gut along its mesenteric stalk
occurs in 60–70% of neonates diagnosed with IM, the
ultimate strangulation in about 15% [4]. Eighty percent of
the patients with symptomatic IM present in their ﬁrst
month of life [5] and require surgery. Delay in diagnosis
may lead to intestinal ischemia, intestinal necrosis, septi-
caemia and short bowel syndrome. The surgical outcome is
negatively inﬂuenced by the presence of intestinal necrosis
[6], and the need for operation during the ﬁrst 3 months of
life [6–9]. To keep mortality and morbidity low, all
asymptomatic children with intestinal malrotation are
advised to undergo semi-elective surgery (Ladd’s proce-
dure) in childhood and adolescence [10, 11].
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syndromes and combinations. Associated serious abnor-
malities increase the mortality risk in patients with IM of
about 22-fold according to Messineo [6]. Commonly
associated congenital malformations are duodenal atresia,
abdominal wall defects or diaphragmatic hernia [3, 12]. It
is more frequently observed in patients with situs inversus
[13] or heterotaxia, a syndrome associated by congenital
cardiovascular defects [14].
Congenital cardiovascular defects (CCVD) are among
the most common congenital birth defects occurring in
about 1 in 100 living births [15]. Congenital malformations
of the gastrointestinal, musculoskeletal and urinary systems
are the most frequently seen extra cardiac malformations in
patients with CCVD [16]. Intestinal malrotation has been
observed in 2.8–4.1% of all the patients with CCVD,
mainly in patients with single ventricle [17]. However, the
incidence of CCVD in IM patients has not been precisely
quantiﬁed in the recent literature and the full array of the
associated cardiac anomalies has not been well described.
The purpose of our study was (1) to delineate and
accurately describe the types and incidence of associated
cardiac lesions in our most recent 25-year experience of
patients with IM, and (2) to study the inﬂuence of a co-
existing CCVDs on IM surgery morbidity and mortality.
Materials and methods
Population
A retrospective review at a single university centre was
conducted on all the paediatric patients diagnosed with IM
born and between September 1980 and September 2005.
Patients with CCVD were identiﬁed for further analysis.
Patients demographics recorded included gestational age,
weight and gender. Data on the type of CCVD, other
congenital defects, known syndromes or associations, post-
operative complications, morbidity and mortality were
collected. The diagnosis of CCVD was based on clinical,
ECG, echocardiography, heart catheterization and peri-
operative ﬁndings. The IM diagnosis was based on radio-
logical upper gastro-intestinal examination, or during acute
surgery.
Data analysis
Collected data were analyzed by calculating prevalence
percentages. Analysis of nominal variables was performed
using cross tables for calculating relative risk (RR) with the
corresponding 95% conﬁdence interval (95% CI). Fisher
extact test was used for comparison of percentages of both
CCVD groups, expressed as P values. For the comparison
of continuous variables, Mann–Whitney U test was used to
calculate P value. The P values are two-sided, and a value
of P = 0.05 was considered statistical signiﬁcant. For the
calculation of risk factors for both post-operative morbidity
and mortality, (adjusted) odds ratios (OR) with consequent
95% CI were calculated by uni- and multi-variate regression
analysis. Statistical analysis was performed using SPSS
software (version 12.0.1; SPSS Inc., Chicago, IL, USA).
Results
Demographics
During a period of 25 years, 284 patients were diagnosed
in our centre with IM. Ninety-three of the 284 patients
were identiﬁed with CCVD as well. Fifteen patients had
persistent pulmonary hypertension (PPHT), all but one
with congenital diaphragmatic hernia. One patient had a
solitary pre-duodenal portal vein. The records of these 16
patients without structural CCVD were excluded, leaving
77 patients with both IM and CCVD (27.1% of the total IM
population in the last 25 years) for further analysis. The
gestational age range was 26–42 weeks with a median of
39 weeks. Median birth weight was 2.86 kg (range 0.72–
4.53). A female predominance was seen with 47 girls
(61%) and 30 boys (39%). Median follow-up period after
IM diagnosis was 2.8 years (range 0–24 years). The overall
survival at the end of follow-up was 80.5% (15 out of 77
patients died).
Congenital cardiovascular defects
The CCVDs were divided into the subgroups, major and
minor CCVDs (see Table 1), varying from small ventric-
ular septal defect (VSD) to common arterial trunk (CAT).
Thirty-seven out of 77 patients (48.1%) were diagnosed
with major CCVD and 40 patients (51.9%) with minor
CCVD.
The characteristics of the whole group (n = 77) as well
as that of the subgroups are described in Table 2. Forty-two
patients underwent cardiac surgery, of which 20 patients
had two or more cardiac surgical interventions. Patients
with major CCVDs needed cardiac surgery more often.
Minor CCVDs that needed surgical intervention most fre-
quent were VSD, atrial septal defects (ASD) and aortic
valve stenosis (AS). Six patients with severe CCVD did not
undergo correction of their heart disease before IM oper-
ation: three patients died (n = 2 due to post IM surgery
complications, n = 1 because of other congenital malfor-
mations). One patient with dextrocardia did not need
258 Pediatr Surg Int (2008) 24:257–263
123cardiac correction. The two patients with Tetralogy of
Fallot (TOF) underwent cardiac correction 6 months after
IM surgery.
Congenital malformations, syndromes and associations
Congenital malformations other than IM and CCVD were
observed in 65 of the 77 (84.4%) patients, see also Table 2.
Most frequently observed congenital malformations inclu-
ded omphalocele (n = 7), congenital diaphragmatic hernia
(n = 7), ano-rectal malformations (n = 6) and heterotaxia
(n = 6).
Syndromes and associations were recognized in 41
(53.2%) patients, of which Down syndrome (n = 7), hetero-
taxia (n = 6), VACTERL (n = 5), Ivemark (n = 5) and
lateralization abnormalities (n = 4) were most frequently
recognized. Kartagener syndrome occurred in two patients.
Several other syndromes all occurred once. Syndromes and
associations were more frequent in patients with major
CCVD.
Intestinal malrotation surgery
Characteristics of IM-operated patients and their major and
minor CCVD subgroups are described in Table 3. Five
patients did not undergo IM surgery yet; in three patients
the surgery was about to take place in the near future, in
one patient no surgical intervention was planned and one
patient died of an unknown cause before IM surgery could
take place. A Ladd procedure was performed for IM cor-
rection. Twenty-eight out of the 72 operated patients
needed acute IM surgery, at a median age of 4.0 days
(range 0–455). Only 4 out of these 28 patients had previ-
ously undergone surgical correction of the CCVD. Five
patients had ischemic bowel disease at time of acute IM
intervention; three of these patients died, one due to mas-
sive intestinal necrosis (one patient died due to
cardiovascular cause, one patient died because of severe
infection). At the time of IM surgery, signs and symptoms
of CCVD, e.g., hepatomegaly, central cyanosis, cardiac
murmurs and respiratory insufﬁciency, were more often
observed twice in patients with a major CCVD (62.2 vs.
Table 1 Types of major and
minor congenital cardiovascular
defects
CCVD Congenital
cardiovascular defects
Major CCVD n = 37 (100%) Minor CCVD n = 40 (100%)
Complex cardiovascular
defects
n = 18 (48.6%) Ventricular septal defect n = 16 (40.0%)
Tetralogy of Fallot n = 7 (18.9%) Atrium septal defect n = 7 (17.5%)
Hypoplastic left heart
syndrome
n = 3 (8.1%) Peripheral pulmonary stenosis n = 4 (10.0%)
Atrioventricular septal defect n = 3 (8.1%) Persistent ductus arteriosus n = 3 (7.5%)
Pulmonary valve atresia n = 1 (2.7%) Pulmonary valve stenosis n = 3 (7.5%)
Transposition of the great
arteries
n = 1 (2.7%) Aortic valve stenosis n = 2 (5.0%)
Tricuspid valve atresia n = 1 (2.7%) Aortic coarctation n = 1 (2.5%)
Common arterial trunk n = 1 (2.7%) Hypertrophic cardiomyopathy n = 1 (2.5%)
Aortic arch hypoplasia n = 1 (2.7%) Subvalvular aortic valve stenosis n = 1 (2.5%)
Dextrocardia n = 1 (2.7%) Left superior caval vein n = 1 (2.5%)
Arteria lusoria n = 1 (2.5%)
Table 2 Characteristics of studied population and its subgroups of congenital cardiovascular defects
Characteristic All CCVD Major CCVD Minor CCVD Relative risk (95% CI)/P value
100% (n = 77) 100% (n = 37) 100% (n = 40)
Boys 39% (n = 30) 35.1% (n = 13) 42.5% (n = 17) 0.85 (0.5–1.4)
Syndromes or associations 53.2% (n = 41) 67.6% (n = 25) 40% (n = 16) 1.8 (1.1–3.1)
Other congenital defects 84.4% (n = 65) 83.8% (n = 31) 85% (n = 34) 0.95 (0.5–1.8)
Cardiac surgery 54.4% (n = 42) 83.8% (n = 31) 27.5% (n = 11) 4.3 (2.0–9.1)
CCVD diagnosed before IM 57.1% (n = 44) 78.4% (n = 29) 37.5% (n = 15) 2.7 (1.4–5.2)
Age at CCVD diagnosis in days [median (range)] 4.5 (0–210) 4 (0–98) 7 (0–210) P = 0.12
Birth weight in kilograms [median (range)] 2.86 (0.72–4.53) 2.96 (0.96–4.53) 2.84 (0.72–4.30) P = 0.4
Age at ﬁrst CCVD surgery in days [median (range)] 102 (2–3,759) 43 (2–3,759) 117 (24–1,705) P = 0.15
Values in bold represent statistical signiﬁcant results
CCVD Congenital cardiovascular defects, IM Intestinal malrotation
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12330.0%, respectively, P = 0.004). Most common compli-
cations were intestinal (Platzbauch, leakage of the bowel
anastomosis resulting in sepsis, feeding difﬁculties with
long-term necessity of nasogastrical tube feeding), infec-
tions and cardiovascular complications (e.g. bradycardia,
thrombosis, arrhythmia) and they did not differ between
both subgroups. Thirteen patients needed relaparotomy
because of leakage of the bowel anastomosis (n = 4),
Platzbauch (n = 2), suspected bowel obstruction with
feeding difﬁculties (n = 1) and necrotising enterocolitis
(n = 1). Five patients were reoperated for an adhesion
ileus, all but one more than 1 month after surgery.
Patients suffering from a post-operative IM surgery
complication were younger (5.5 vs. 94.5 days, P = 0.031)
and had a lower body weight (2.86 vs. 4.84 kg, P = 0.003)
at time of IM surgery. Major CCVD, co-occurrence of a
syndrome, or other congenital malformations did not sig-
niﬁcantly increase the risk on post-IM-operative morbidity.
Correction for age and weight at the time of IM surgery in
both CCVD groups showed, although not signiﬁcant, a
clear trend in post-IM-operative morbidity risk in patients
diagnosed major CCVD (OR 2.9, 95% CI 0.9–9.6). Patients
with pre-operative signs of CCVD had a four times
increased risk on post-operative complications (95% CI
1.4–11.0). This risk factor was more prominent after cor-
rection for age and weight at the time of IM surgery (OR
8.2, 95% CI 2.1–30.7).
Mortality
Fifteen (19.5%) out of 77 patients died, 9 with major
CCVDs. One patient with a minor CCVD died prior to IM
surgery at the age of 1.4 years; cause of death remained
unclear. Known causes of death after IM surgery were:
cardiovascular complications (n = 7), massive intestinal
necrosis (n = 2), sepsis (n = 2), respiratory failure (n =2 )
and abstention of medical care because of unsuccessful
surgical intervention on malformed trachea (n = 1). In both
CCVD groups, death due to a cardiovascular cause
remained the most frequent one. Median age at time of
death was 40.5 days (range 3–3,010), with a median of
28.5 days after IM surgery (range 0–1,814). Of the 14
deceased patients, 9 (64.3%) had a major CCVD. Median
age at time of death in the major CCVD group was 46 days
(range 22–3,010) and in the minor CCVD group 8 days
(range 3–60 days), although this difference was statisti-
cally not signiﬁcant (P = 0.4). Twenty percent of the
patients (7/35) with pre-operative physical signs of CCVD
died, only one due to a cardiovascular cause. Three out of
ﬁve patients with ischemic bowel at the time of IM surgery
died post-operatively. The risk factors for mortality are
shown in Table 4.
Discussion
This study addresses the co-existence of malrotation with
different types of congenital cardiovascular defects. We
found 27.1% of all the patients registered in the last
25 years for IM to have a major or minor CCVD. Major
CCVDs were seen in almost half of our population. Stewart
et al. [2] found only 12% in a smaller IM population to
have any CCVD. Complex CCVDs (23% of our popula-
tion, 6.3% of all patients with IM in the last 25 years) and
VSDs (21% of our population, 5.6% of all patients with IM
in the last 25 years) were most frequently diagnosed. Pra-
dat et al. [17] reported the co-occurrence of IM in patients
with single ventricle to be as high as 8.5%. Further data on
co-occurrence of CCVD in IM patients are missing.
The high prevalence of the CCVD in our IM cohort needs
some thoughts on common aetiology. The gut is developed
at a later stage in embryogenesis than the heart does.
Abnormal abdominal development, e.g. by early
Table 3 Characteristics of general population, major and minor congenital cardiovascular defects groups operated on intestinal malrotation
Characteristic All CCVD Major CCVD Minor CCVD P value
IM surgery 100% (n = 72) 100% (n = 34) 100% (n = 38) -
Physical signs CCVD prior to IM surgery 48.6% (n = 35) 67.6% (n = 23) 30.0% (n = 12) 0.004
Post-IM-operative complications 61.1% (n = 44) 67.6% (n = 23) 55.3% (n = 21) 0.3
Post-IM-operative cardiovascular complications 18.1% (n = 13) 20.6% (n = 7) 15.8% (n = 6) 0.8
Relaparotomy 18.1% (n = 13) 17.6% (n = 6) 18.4% (n = 7) 1.0
Age at IM surgery in days [median (range)] 17 (0–1,293) 104 (0–1,196) 6 (0–1,293) 0.006
Weight at IM surgery in kilograms [median (range)] 3.21 (1.20–11.4) 4.84 (1.20–11.4) 2.88 (1.24–10.6) 0.02
Death in days after IM surgery [median (range)] 28 (0–1,814) 33 (0–1,814) 3 (3–59) 0.2
Age at death in days [median (range)] 40.5 (3–3,010) 46 (22–3,010) 8 (3–60) 0.1
Values in bold represent statistical signiﬁcant results
CCVD Congenital cardiovascular defects, IM Intestinal malrotation
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123development of an intra-abdominal cyst in embryogenesis,
is known to enhance the chance of developing IM [18].
Changes in intra-abdominal space caused by a CCVD might
also increase the risk on IM development during embryo-
genesis[4].Anotherexplanationmightbeacommongenetic
cause. The gut and the heart are both organs that show a
characteristic left–right asymmetry, caused by a speciﬁc
biochemical cascade during embryogenesis [19]. Two sig-
nalling molecules inevitable for this cardiac and gastro-
intestinal asymmetry are nodal and pitx2c [20]. Reduced,
diffuse or absent expression of pitx2c in the embryo cause
abnormal looping from both heart and gut in animal studies
[21–24], resulting mainly in abnormal outﬂow tract orien-
tation (e.g. unseptated and misaligned great artery trunks,
symmetrical outﬂow tract cushions, double outlet right
ventricle, common atrioventricular trunk) [23, 24]. This
disturbed expression of pitx2c could cause a spectrum of
isomerism[25].More research isneeded torevealapossible
common genetic cause for both CCVD and IM.
Our study group explores a high percentage of syn-
dromes or associations. Although IM has been recognized
in many syndromes and associations, this high prevalence
should make us aware of co-occurrence of CCVD in these
patients, as well as the possibility of a syndrome or asso-
ciation in patients diagnosed with both IM and CCVD. The
post-operative morbidity after IM surgery in the general
paediatric population is between 0 and 16.7% [9, 26]. A
higher morbidity rate (47%) has been reported by Murphy
et al. [27], yet the surgical intervention was acute in 65% of
their study population. Consistent with earlier reports [6–
8], we found post-operative morbidity and mortality to be
associated with younger age at the time of surgery. How-
ever, ischemic bowel (at the time of IM surgery) did not
increase post-IM-operative morbidity as reported by others
[2, 6, 8, 28]. Re-laparotomy in our population was con-
sistent with earlier reports in the general population [26,
27]. The current study showed that patients with a CCVD
had a relatively high morbidity rate after IM surgery
(61.1%). Syndromes, associations or the presence of other
congenital malformations were not found to be risk factors
for post IM morbidity. Cardiovascular complications were
seen in 18.1% of our population. There are neither data on
prevalence of cardiovascular complications after IM sur-
gery in the general paediatric population, nor on inﬂuence
of physical condition prior to IM surgery on the morbidity
after the operation. Although the type of CCVD was not
signiﬁcantly associated with an increased risk on morbi-
dity, there was a clear trend (towards increased risk on
post-operative morbidity) in patients with major CCVD.
Furthermore, patients with pre-operative physical signs of
CCVD had a high post-operative morbidity rate (77%).
The overall mortality rate in literature after IM surgery
varies between 3 and 9% [6, 27–29]. Ilc ¸e et al. [8] found a
mortality rate varying between 0 and 36% in patients
mainly younger than 1 year, having almost all emergency
intervention. A recent study of Murphy et al. [27] reported
only 1 post-operative death in 46 patients due to cardio-
vascular consequences in a patient with congenital cyanotic
Table 4 Risk factors
(expressed as odds ratios and
95% conﬁdence interval) for
mortality in the whole study
population (n = 77)
Values in bold represent
statistical signiﬁcant results
CCVD Congenital
cardiovascular defects,
IM Intestinal malrotation
Characteristic Deceased Alive Odds ratio
(95% CI)
Adjusting for weight
and age at time of
IM surgery OR (95% CI)
Major CCVD 9 28 1.8 (0.6–5.7)
5.0 (1.2–20.7)
Minor CCVD 6 34
Syndrome/association 7 34 0.7 (0.2–2.2) 1.0 (0.3–3.4)
No syndrome or association 8 28
Other congenital defects 13 52 1.3 (0.2–6.4) 1.1 (0.2–5.9)
No other congenital defects 2 10
Physical CCVD signs prior to
IM-surgery
7 28 1.1 (0.3–3.4) 1.3 (0.4–4.4)
No physical CCVD signs prior to
IM-surgery
73 0
Intestinal ischemia 3 2
7.6 (1.1–51.2)
5.9 (0.9–42.4)
No intestinal ischemia 11 56
Post-IM-operative complications 1 27
11.3 (1.4–92.3) 8.7 (1.0–75.7)
No post-IM-operative
complications
13 31
Post-IM operative cardiovascular
complications
76
5.5 (1.5–20.5) 4.5 (1.1–18.4)
No post-IM-operative
cardiovascular complications
85 1
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123heart disease. In the current study, the mortality rate was
higher: almost one-ﬁfth of the patients died. Patients who
died were signiﬁcantly younger at the time of IM surgery.
Other risk factors for death were major CCVD (after cor-
rection for age and weight at the time of IM surgery),
ischemic bowel at the time of IM surgery, post-IM-opera-
tive complications in general and post-IM-operative
cardiovascular complications.
Diagnosis and treatment of cardiac diseases have
incredibly improved in the last two decades. Associated
congenital abnormalities, including IM, have increased in
signiﬁcance. However, since mortality rates after surgical
intervention for IM in patients with an associated CCVD
are high, intervention should be well thought over. Recent
studies discuss the advantages of laparoscopic inspection
for IM, also in acute paediatric abdomen [30]. No data on
laparoscopy in IM patients with CCVD are available.
Possible advantages of laparoscopy for IM diagnosis, fol-
lowed by operation, even in acute cases, might improve the
outcome [30], even in patients with major CCVD. Referral
to a centre equipped with paediatric cardioanesthesio-
logical care is imperative.
Study limitations
This is a retrospective study of all consecutive live-born IM
patients referred to a single university centre over a 25-year
period. There are asymptomatic IM patients who never
consult a doctor. Patients with IM and a very mild CCVD
might have been missed. Screening for CCVD in IM
patients could give us more information on the exact
prevalence of CCVD in IM patients. Furthermore, since
CCVD are very common congenital defects, a prospective
study on the prevalence of IM in all patients with minor
and major CCVD would also be of great interest.
Each retrospective study has its limitations, e.g. some
variables were not (yet) available; e.g. syndromes and
associations were common in our study population. Yet,
the actual prevalence of syndromes might have been higher
than reported. Certain syndromes and associations are quite
new and nowadays there might be more attention on
searching for a ﬁtting syndrome or association diagnosis
than 20 years ago.
As regards treatment, we perform 3 years laparoscopic
inspection,followedbycorrectionoftheanomalybylaparo-
scopy or laparotomy in very young children [31].
Conclusion
The prevalence of CCVD in patients with IM is high
(27.1%). Major and minor CCVDs are both frequently
seen. Major CCVD is a risk factor for death after IM
operation. Since morbidity and mortality rates in IM
patients with CCVD are much higher than previously
reported, a pre-operative screening for co-existing CCVD
is indicated. Elective IM surgery in young patients with
major CCVD should be conducted in a centre with ade-
quate paediatric cardiac care. The beneﬁt of laparoscopic
intervention needs further follow-up.
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